Shaw Christi
SEC CIK 1702473 · EDGAR
Most active insiders at KYTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Westlake BioPartners Opportunity Fund I, L.P. | 10% | $1000.0K | — |
| 2 | SEIDENBERG BETH C | Dir | $1000.0K | — |
| 3 | Walker Karen Marie | CTO | — | $292.8K |
| 4 | GEHCHAN NAJI | See Remarks | — | — |
| 5 | Aktar Mert | Dir | — | — |
| 6 | Biddle Warner Weston | CEO, Dir | — | — |
| 7 | Emany Sravan Kumar | Dir | — | — |
| 8 | Miller Andrew Craig | Dir | — | — |
| 9 | GRASSO MARC | CFO | — | — |
| 10 | Shaw Christi | Executive COB, Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 16:30 | 2026-05-27 | KYTX | Kyverna Therapeutics, Inc. | Shaw Christi | Executive COB, Dir | F - Tax | $8.59 | -4,194 | 66.7K | -6% | -$36.0K | |
| DM | 2026-01-14 | 2026-01-12 | KYTX | Kyverna Therapeutics, Inc. | Shaw Christi | Executive COB, Dir | A - Grant | $0.00 | +54.3K | 70.9K | +326% | $0 |
| D | 2025-06-02 | 2025-05-29 | KYTX | Kyverna Therapeutics, Inc. | Shaw Christi | Dir | A - Grant | $0.00 | +16.6K | 16.6K | New | $0 |
| 2023-05-15 | 2023-05-11 | AVTR | Avantor, Inc. | Shaw Christi | Dir | A - Grant | $0.00 | +9,808 | 36.3K | +37% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | Avantor, Inc. | Shaw Christi | Dir | A - Grant | $0.00 | +6,693 | 26.5K | +34% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | Avantor, Inc. | Shaw Christi | Dir | A - Grant | $0.00 | +1,215 | 19.8K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations